Skip to main content
. 2013 Jun 25;8(6):e66182. doi: 10.1371/journal.pone.0066182

Figure 2. Comparison of FGF23 concentration between patients with end-stage liver disease (ESLD) or normal liver function (control).

Figure 2

(A) Glomerular filtration rate (GFR) was not different between patients with ESLD and controls. (B) FGF23 concentration was significantly higher in patients with ESLD than in control subjects (p<0.0001). Results are mean ± SD.